▲ BUY
9
/ 10
Conviction
$ Value
$36K
Shares
4,233
Price
$8
Filed
May 14
▶ Why this score? (9/10)
- ✓ Open market buy (+3)
- ✓ % of holdings >= 50% (+3)
- ✓ C-suite insider (+2)
- ✓ Not a 10b5-1 plan (+1)
Insider
Name
ELDER WILLIAM ROBERT
Title
CFO, GC & Secretary
CIK
0001828068
Roles
Officer
Transaction Details
Transaction Date
2025-05-14
Code
P
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
5,500
Footnotes
Shares purchased in open-market transactions. | Represents weighted average price of (i) 3,800 shares purchased at $8.4499 per share and (ii) 433 shares purchased at $8.5373 per share.
Filing Info
ELDER WILLIAM ROBERT's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-02-11 | CRVO | A | $0 |
| 2025-11-18 | CRVO | ▲ | $21K |
| 2025-11-17 | CRVO | ▲ | $8K |
| 2025-11-12 | CRVO | ▲ | $26K |
| 2025-05-14 | CRVO | ▲ | $36K ★ |
Other Insiders at CRVO (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
ALAM JOHN J
CEO & President
|
— | — | 2026-02-11 |
| Gregoire Sylvie | — | — | 2026-02-11 |
|
Blackburn Kelly
EVP, Clinical Development
|
— | — | 2026-02-11 |
|
ELDER WILLIAM ROBERT
CFO, GC & Secretary
|
— | — | 2026-02-11 |
|
De Rosch Mark
EVP, RA and GA and PgM
|
— | — | 2026-02-11 |
|
Winton Matthew
Chief Commercial and Business
|
— | — | 2026-02-11 |